found
niedbala
collison
almost
simultan
report
contain
chain
chain
epsteinbarr
virusinduc
gene
connect
disulfid
bond
initi
name
intern
congress
immunolog
new
focu
cytokin
research
similar
famili
member
heterodimer
glycoprotein
form
disulfidelink
chain
bundl
typic
cytokin
structur
homolog
solubl
cytokin
receptor
combin
form
combin
form
combin
form
compos
differ
express
secret
way
member
respons
bacteria
bacteri
product
intracellular
parasit
secret
activ
antigenpres
cell
includ
b
cell
monocyt
macrophag
dendrit
cell
initi
report
produc
treg
cell
essenti
maxim
inhibitori
role
treg
cell
recent
studi
suggest
regulatori
b
cell
breg
also
produc
fusion
protein
induc
breg
cell
secret
peptid
chain
share
common
famili
bind
receptor
activ
signal
transduc
activ
transcript
stat
protein
uniqu
antiinflammatori
cytokin
contrast
proinflammatori
cytokin
differ
thought
associ
receptor
signal
pathway
specif
futur
studi
confirm
assert
obstacl
understand
molecular
mechan
underli
lack
clariti
receptor
signal
transduct
pathway
collison
group
report
mous
differ
tradit
cytokin
receptor
compos
dimer
homodim
homodim
il
heterodim
bind
initi
signal
transduct
exert
biolog
function
homodim
activ
heterodim
form
induc
signal
pathway
mediat
treg
cell
function
posit
neg
feedback
regul
gene
express
report
activ
cell
bind
receptor
depend
jakstat
signal
introduc
intracellular
respons
howev
b
cell
signal
mediat
activ
heterodim
fig
b
cell
tradit
thought
contribut
immun
defens
secret
antibodi
antigen
present
also
function
immun
regul
breg
cell
multipl
b
cell
subset
immun
regul
function
plasma
cell
cell
transit
zone
precursor
cell
b
cell
breg
cell
unifi
determin
phenotyp
gener
recogn
breg
cell
play
role
immunosuppress
function
secret
stimul
tolllik
receptor
tlr
agonist
furthermor
immunosuppress
pathway
breg
cell
may
sole
depend
research
suggest
breg
cell
produc
induc
breg
cell
secret
bcellderiv
also
act
cellinduc
treg
cell
fig
although
inhibit
b
cell
prolifer
select
induc
breg
cell
prolifer
vivo
unlik
cell
inhibit
small
interf
rna
sirna
neutral
antibodi
affect
b
cell
prolifer
secret
contrast
silenc
b
cell
complet
block
inhibit
function
thu
may
mediat
biolog
activ
differ
cell
type
via
differ
receptor
stat
signal
pathway
futur
studi
requir
confirm
novel
inhibitori
cytokin
may
specif
produc
treg
cell
requir
maxim
suppress
activ
treg
addit
block
prolifer
cell
limit
earli
cell
rest
phase
cell
divis
although
inhibit
prolifer
resist
treg
convers
due
potent
inhibit
transcript
moreov
block
develop
repress
express
limit
prolifer
also
mediat
convers
cell
treg
although
block
like
induc
develop
induc
regulatori
cell
itreg
popul
suppress
tcell
prolifer
via
itreg
express
fig
effect
ntreg
restor
immun
homeostasi
prevent
autoimmun
diseas
mice
limit
prolifer
cell
prevent
model
eae
ibd
promot
prolifer
tumor
cell
adopt
transfer
treatment
increas
prolifer
cell
secret
autoimmun
protect
collageninduc
arthriti
model
howev
whether
presenc
mediat
treg
amplif
physiolog
condit
still
uncertain
fairli
ubiquit
express
express
mainli
surfac
activ
cell
natur
killer
cell
b
cell
dendrit
cell
undetect
rest
cell
rapidli
upregul
exposur
inde
pretreat
increas
cell
sensit
mediat
suppress
mediat
inhibitori
effect
cell
signal
pathway
also
lead
proinflammatori
effect
activ
stat
molecul
key
differ
induc
heterodim
format
highli
purifi
heterodimer
cytokin
difficult
obtain
limit
immunolog
research
especi
elucid
role
cytokin
autoimmun
infecti
diseas
tumor
immun
transgen
technolog
appli
infect
cell
establish
mous
model
heterodim
similar
secret
disulfidelink
heterodim
associ
noncoval
nativ
heterodim
would
difficultli
isol
vivo
secret
coprecipit
vitro
express
studi
cell
meanwhil
absenc
substanti
amount
degrad
er
endoplasm
reticulum
therebi
reduc
bioavail
contribut
low
level
vivo
other
gener
recombin
mous
use
bicistron
vector
contain
ire
intern
ribosom
entri
site
allow
stoichio
etric
express
anoth
approach
use
construct
heterodimer
protein
coval
link
previou
work
suggest
play
role
tumor
immun
escap
express
increas
hodgkin
lymphoma
treg
cell
inhibitori
cytokin
note
peripher
blood
tumor
microenviron
patient
pancreat
breast
carcinoma
express
lung
cancer
cell
also
found
associ
tumor
progress
sirnamedi
downregul
gene
inhibit
prolifer
lung
cancer
cell
similarli
inocul
tumor
cell
mice
show
enhanc
antitumor
immun
rel
wildtyp
mice
metastat
potenti
tumor
cell
suppress
tumor
cell
microenviron
studi
show
signific
increas
myeloidderiv
suppressor
cell
mdsc
vascular
endotheli
growth
factor
promot
tumor
angiogenesi
mdsc
immunosuppress
inhibit
cytotox
cell
way
tumor
cellgener
may
protect
cytotox
tcellmedi
damag
contrast
applic
neutral
antibodi
significantli
inhibit
tumor
cell
prolifer
although
mani
studi
shown
contribut
immunosuppress
function
mous
model
effect
limit
human
express
treg
cell
observ
earli
investig
human
suggest
may
constitut
express
human
howev
produc
specif
tissu
cell
type
certain
inflammatori
stimulu
recent
studi
shown
strong
stimul
treg
produc
cell
stimul
express
mice
similarli
human
treg
suppress
immun
respons
prostat
cancer
express
although
research
requir
draw
conclus
preliminari
inform
suggest
elev
serum
associ
tumor
malign
clinic
stage
decreas
associ
autoimmun
diseas
chronic
infect
fig
inhibitori
cytokin
play
import
role
infecti
diseas
studi
suggest
mycobacterium
tuberculosi
tuberculosi
could
induc
cell
prolifer
foster
product
mice
defici
mice
wildtyp
mice
thu
elimin
pathogen
mice
lack
found
less
abl
show
antigenspecif
respons
lack
subunit
howev
abil
counteract
infect
less
pronounc
wildtyp
mice
addit
protect
respons
induc
wildtyp
mice
inocul
vaccin
increas
secret
howev
mice
produc
antigenspecif
increas
infect
load
bacteria
addit
treatment
mice
candida
albican
c
albican
reduc
rate
fungal
infect
associ
littl
obviou
symptom
infect
rel
mice
mice
gene
disrupt
immunosuppress
function
inhibit
impair
antifung
immun
cell
peripher
blood
patient
chronic
hepat
b
also
show
high
level
express
protein
indic
relat
immun
respons
chronic
hepat
b
patient
result
show
acut
infect
process
preferenti
activ
cell
stimul
prolifer
treg
cell
inhibit
differenti
cell
therebi
prevent
excess
tissu
damag
caus
clear
pathogen
chronic
infect
inflamm
select
inhibit
effector
cell
includ
cell
slow
develop
autoimmun
diseas
fig
bcell
regul
expand
regulatori
rang
alter
view
chief
immun
mechan
breg
cell
secret
signal
mediat
activ
b
cell
bind
receptor
induc
treg
cell
provid
mutual
stimul
inflamm
amplif
regulatori
cell
b
cell
also
transform
secretari
breg
cell
breg
cell
control
incid
develop
eau
induc
breg
cell
induc
treg
cell
case
inflamm
cell
gener
provid
mutual
stimul
result
amplif
regulatori
cell
recent
research
found
inflammatori
stimulu
condit
also
play
immunomodulatori
role
human
bodi
look
forward
explor
immunotherapi
approach
futur
studi
may
address
whether
share
receptor
member
may
help
clarifi
biolog
effect
identifi
cell
type
subtyp
involv
immun
regul
produc
inhibit
cell
prolifer
differ
cell
mediat
differ
signal
pathway
potenti
prospect
clinic
use
breg
cell
chemotherapeut
treat
autoimmun
diseas
organ
transplant
also
await
studi
